AUG 17, 2026 · PHASE 3 TRIAL
Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients
ClinicalTrials.gov
This is a clinical trial registry record describing an active Phase 3 study with no results yet posted; the trial is ongoing and no efficacy or safety data are available for analysis.
Reported
Phase3
Planned enrollment293
Primary outcome measureTime to first subsequent treatment (TFST) i…